Friday 6 November 2026 Export JAZZ’s income statement to Excel — free account

Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals PLC’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 4.88% from fiscal 2024.

Revenue: +10.4%
EPS: −280.5%
Free cash flow: −60.4%
Total debt: +3.88%

Quarter to September 2026, against a year earlier

Revenue growth 10 yrs

235.28 7.96 +3.50%

Follow JAZZ

Alert me

Market cap: $14.6B
P/E: 62.6×
Fwd P/E: 35.9×
Dividend yield: —
F-score: 5/9
Altman Z: 1.37
Beneish M: −3.03
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	410.98	15.80	63.63
P/S ratio Full definition →		2.43	2.64	3.31	3.17
P/FCF ratio Full definition →		32.79	37.30	10.75	22.54
P/Operating CF Full definition →		28.60	28.67	36.64	29.60
P/B ratio Full definition →		2.40	2.58	3.17	3.57
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		3.11	3.20	3.78	3.75
EV/EBITDA Full definition →		49.93	21.01	10.76	15.46
EV/Operating CF Full definition →		9.80	10.63	10.46	10.45
EV/FCF Full definition →		42.02	45.21	12.27	26.62
Quick Ratio Full definition →		1.46	1.65	1.38	1.47
Current Ratio Full definition →		1.86	2.04	1.78	1.82
Net Debt/EBITDA Full definition →		6.72	4.79	5.04	(11.57)
Debt/Assets Full definition →		45.96%	45.15%	39.27%	46.42%
Debt/Equity Full definition →		1.24	1.18	0.91	1.33
Asset Turnover Full definition →		0.36	0.38	0.42	0.40
Operating CF/Net income Full definition →		1.78	1.39	2.16	(1.05)
Capex/Depreciation Full definition →		(5.02)	(0.11)	(0.53)	(0.07)
Interest Coverage Full definition →		5.61	8.44	6.69	(9.09)
Research and Development Expense of Revenue Full definition →		17.86%	18.34%	17.17%	17.05%
Selling, General and Administrative Expense of Revenue Full definition →		33.91%	33.00%	32.21%	32.82%
Intangible Assets out of Total Assets Full definition →		0.54	0.51	0.53	0.50
Share Based Compensation of Revenue Full definition →		5.91%	6.97%	6.07%	6.21%
Graham Net Nets Full definition →		(0.31)	(0.23)	(0.15)	(0.21)
Graham Number Full definition →		0.00	27.53	161.46	72.83
Earnings Yield Full definition →		(3.41%)	0.24%	6.33%	1.57%
Free Cash Flow Yield Full definition →		3.05%	2.68%	9.30%	4.44%
Revenue per Share Full definition →		19.65	17.27	19.12	19.21
Operating CF per Share Full definition →		5.94	6.59	6.58	7.82
Capex per Share Full definition →		(14.76)	(0.32)	(1.50)	(0.20)
Free Cash Flow per Share Full definition →		(8.82)	6.28	5.07	7.62
Cash per Share Full definition →		40.04	46.43	34.81	44.15
Shareholders Equity per Share Full definition →		70.82	73.22	75.98	64.79
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		70.82	73.22	75.98	64.79
Free Cash Flow Full definition →		(537.66)	388.50	320.60	493.10
Working Capital Full definition →		1,923.50	2,336.50	1,737.40	2,080.20
Capital Expenditures Full definition →		(900.14)	(19.70)	(95.10)	(13.00)
Net Current Asset Value Full definition →		(3,174.70)	(2,744.20)	(2,311.00)	(3,192.50)
EV/EBIT Full definition →		0.00	0.00	19.38	41.54
Capex to Sales Full definition →		0.75	0.02	0.08	0.01
Price to Operating Income Full definition →		0.00	0.00	16.98	35.17
Other line items
Average Receivables Full definition →		773.73	744.65	797.45	819.03
Average Payables Full definition →		99.98	97.97	108.93	266.26
Average Inventory Full definition →		448.72	465.14	473.99	468.56
Average Assets Full definition →		11,835.78	11,697.14	11,012.52	11,677.10
Average Common Equity Full definition →		4,206.18	4,353.60	4,254.03	4,075.42

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly